Full Text View
Tabular View
No Study Results Posted
Related Studies
Evaluating the Transporter Protein Inhibitor Probenecid In Patients With Epilepsy
This study is currently recruiting participants.
Study NCT00610532   Information provided by Ohio State University
First Received: January 28, 2008   Last Updated: September 22, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Epilepsy
More general conditions related to this trial
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Interventions listed in this trial
phenytoin
phenytoin and probenecid
Additional drug interventions recognized in this trial
Probenecid
More general drug interventions related to this trial
Anticonvulsants
Antirheumatic Agents
Central Nervous System Agents
Gout Suppressants
Pharmacologic Actions
Renal Agents
Therapeutic Uses
Uricosuric Agents
Sponsors listed in this trial
Ohio State University


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services